普通病房COVID-19患者深静脉血栓的患病率及其与临床和实验室变量的关联
该研究于2020年3月1日至4月5日对1012例住院COVID-19患者中的263例随机行下肢静脉双功超声筛查,检出深静脉血栓67例(25.5%),住院死亡41例(15.6%)。多因素logistic回归显示仅C反应蛋白(OR 1.009,95%CI 1.004-1.013,P<0.001)与深静脉血栓独立相关;年龄(OR 1.101,95%CI 1.054-1.150,P<0.001)和C反应蛋白(OR 1.012,95%CI 1.006-1.018,P<0.001)与院内死亡独立相关。
要点
- 普通病房COVID-19患者下肢静脉双功超声深静脉血栓患病率为25.5%(67/263)。
- 仅C反应蛋白与深静脉血栓独立相关(OR 1.009,95%CI 1.004-1.013,P<0.001)。
- 年龄和C反应蛋白与院内死亡独立相关,D-二聚体未显示独立关联。
核心结论
- 普通病房COVID-19患者深静脉血栓患病率为25.5%,提示对COVID-19患者筛查这一潜在严重但可治疗的并发症可能是合理的。
- 炎症(以血清C反应蛋白衡量)是与深静脉血栓存在相关的主要变量,其他临床或实验室变量(包括年龄和D-二聚体)均与深静脉血栓无独立关联。
研究设计与样本
- 研究类型为在普通病房住院的COVID-19患者中以随机方式行下肢静脉双功超声筛查。
- 筛查时间为2020年3月1日至2020年4月5日,共筛查263例,占同期住院COVID-19患者1012例中的一部分。
- 参考标准为下肢静脉双功超声,筛查时不参考疾病的症状和体征。
- 次要终点为院内死亡。
诊断标准与关键数值
- 深静脉血栓检出67例,占筛查263例的25.5%。
- 院内死亡41例,占筛查263例的15.6%。
- 多因素logistic回归中仅C反应蛋白与深静脉血栓存在独立关联(OR 1.009,95%CI 1.004-1.013,P<0.001)。
- 年龄(OR 1.101,95%CI 1.054-1.150,P<0.001)和C反应蛋白(OR 1.012,95%CI 1.006-1.018,P<0.001)与院内死亡独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Preliminary reports suggest a hypercoagulable state in COVID-19. Deep vein thrombosis (DVT) is perceived as a frequent finding in hospitalized COVID-19 patients, but data describing the prevalence of DVT are lacking.
OBJECTIVES: We aimed to report the prevalence of DVT in COVID-19 patients in general wards, blinded to symptoms/signs of disease, using lower extremities duplex ultrasound (LEDUS) in random patients. We tested the association of DVT with clinical, laboratory and inflammatory markers and also reported on the secondary endpoint of in-hospital mortality.
PATIENTS/METHODS: n = 263 COVID-19 patients were screened with LEDUS between March 01, 2020 and April 05, 2020 out of the overall n = 1012 admitted with COVID-19.
RESULTS: DVT was detected in n = 67 screened patients (25.5%), n = 41 patients (15.6%) died during the index hospitalization. Multiple logistic regression demonstrated that only C-reactive protein (odds ratio 1.009, 95% CI 1.004-1.013, p < 0.001) was independently associated with the presence of DVT at LEDUS. Both age (odds ratio 1.101, 95% CI 1.054-1.150, p < 0.001) and C-reactive protein (odds ratio 1.012, 95% CI 1.006-1.018, p < 0.001) were instead significantly independently associated with in-hospital mortality.
CONCLUSIONS: The main study finding is that DVT prevalence in COVID-19 patients admitted to general wards is 25.5%, suggesting it may be reasonable to screen COVID-19 patients for this potentially severe but treatable complication, and that inflammation, measured with serum C-reactive protein, is the main variable associated with the presence of DVT, where all other clinical or laboratory variables, age or D-dimer included, are instead not independently associated with DVT.
引用
- Ierardi AM, Gaibazzi N, Tuttolomondo D, et al. Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variables. Radiol Med. 2021. PMID: 33469817. doi:10.1007/s11547-020-01312-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。